The end-stage renal disease industry and exit strategies for nephrologists.
The purpose of this presentation is to identify exit strategies for nephrologists under changing conditions in the dialysis market. The end-stage renal disease service provider market continues to be highly receptive to consolidation. Taking advantage of large economies of scale, large for-profit dialysis chains have surpassed independent operators in both number of clinics and total patients. With relatively low barriers to entry, new smaller clinics continue to open, serving a niche outside the larger chains. Additional competition comes in the form of medium players funded by venture capitalists with the added pressure of rapid growth and financial return. To ensure market power in both dialysis products and managed care negotiation leverage, medium and large service providers will continue to seek out attractive acquisition targets. For nephrologists to capitalize on investment, clinic and business preparation will continue to be the driving force for these divestitures.
Sullivan
John D
JD
Boston University, Boston, MA 02215, USA. jsulliva@bu.edu
D003132:Commerce / Q000458:organization & administration*; D032982:Contracts; D004465:Economic Competition; D006801:Humans; D007676:Kidney Failure, Chronic; D009398:Nephrology; D010820:Physicians